Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Anderson, R. M.
and
May, R. M.
1985.
Age-related changes in the rate of disease transmission: implications for the design of vaccination programmes.
Journal of Hygiene,
Vol. 94,
Issue. 3,
p.
365.
Anderson, Roy M.
and
May, Robert M.
1985.
Vaccination and herd immunity to infectious diseases.
Nature,
Vol. 318,
Issue. 6044,
p.
323.
Britten, N
and
Wadsworth, J
1986.
Long term respiratory sequelae of whooping cough in a nationally representative sample..
BMJ,
Vol. 292,
Issue. 6518,
p.
441.
Anderson, R. M.
and
Grenfell, B. T.
1986.
Quantitative investigations of different vaccination policies for the control of congenital rubella syndrome (CRS) in the United Kingdom.
Journal of Hygiene,
Vol. 96,
Issue. 2,
p.
305.
Robertson, Peter W.
Goldberg, Hazel
Jarvie, Brian H.
Smith, Douglas D.
and
Whybin, L. Ross
1987.
Bordetella pertussis
infection: a cause of persistent cough in adults
.
Medical Journal of Australia,
Vol. 146,
Issue. 10,
p.
522.
Muller, A S
Leeuwenburg, J
and
Pratt, David S
1987.
Epidemiology and Control of Pertussis.
Tropical Doctor,
Vol. 17,
Issue. 4,
p.
182.
Stroffolini, T.
Giammanco, A.
Taormina, S.
Nisticò, L.
Chiarini, A.
De Crescenzo, L.
Cascio, A.
Lupo, F.
Nicosia, V.
Torres, G.
and
Valenza, A. R.
1989.
Prevalence of pertussis IgG antibodies in children in Palermo, Italy.
Infection,
Vol. 17,
Issue. 5,
p.
280.
1989.
Pertussis in England and Wales: an investigation of transmission dynamics and control by mass vaccination.
Proceedings of the Royal Society of London. B. Biological Sciences,
Vol. 236,
Issue. 1284,
p.
213.
Bundy, D.A.P.
1990.
Control of intestinal nematode infections by chemotherapy: mass treatment versus diagnostic screening.
Transactions of the Royal Society of Tropical Medicine and Hygiene,
Vol. 84,
Issue. 5,
p.
622.
Mortimer, Edward A.
1991.
Bacterial Infections of Humans.
p.
499.
Cahill, Edward S.
O'Hagan, Derek T.
Illum, Lisbeth
and
Redhead, Keith
1993.
Mice are protected againstBordetella pertussisinfection by intra-nasal immunization with filamentous haemagglutinin.
FEMS Microbiology Letters,
Vol. 107,
Issue. 2-3,
p.
211.
Loosmore, Sheena
Zealey, Gavin
and
Klein, Michel
1994.
Modern Vaccinology.
p.
319.
Hethcote, Herbert W.
1997.
An age-structured model for pertussis transmission.
Mathematical Biosciences,
Vol. 145,
Issue. 2,
p.
89.
Mortimer, Edward A.
1998.
Bacterial Infections of Humans.
p.
529.
van Boven, Michiel
de Melker, Hester E.
Schellekens, Joop F.P.
and
Kretzschmar, Mirjam
2000.
Waning immunity and sub-clinical infection in an epidemic model: implications for pertussis in The Netherlands.
Mathematical Biosciences,
Vol. 164,
Issue. 2,
p.
161.
Edmunds, W.John
Brisson, Marc
Melegaro, Alessia
and
Gay, Nigel J.
2002.
The potential cost-effectiveness of acellular pertussis booster vaccination in England and Wales.
Vaccine,
Vol. 20,
Issue. 9-10,
p.
1316.
Girard, Dorota Z.
2002.
Which Strategy for Pertussis Vaccination Today?.
Pediatric Drugs,
Vol. 4,
Issue. 5,
p.
299.
Girard, Dorota Z.
2002.
Which Strategy for Pertussis Vaccination Today?.
Pediatric Drugs,
Vol. 4,
Issue. 5,
p.
299.
Isaka, Masanori
Yasuda, Yoko
Taniguchi, Tooru
Kozuka, Satoshi
Matano, Keiko
Maeyama, Jun-ichi
Morokuma, Kazunori
Ohkuma, Kunio
Goto, Norihisa
and
Tochikubo, Kunio
2003.
Mucosal and systemic antibody responses against an acellular pertussis vaccine in mice after intranasal co-administration with recombinant cholera toxin B subunit as an adjuvant.
Vaccine,
Vol. 21,
Issue. 11-12,
p.
1165.
Godfroid, Fabrice
Denoël, Philippe
and
Poolman, Jan
2005.
Are vaccination programs and isolate polymorphism linked to pertussis re-emergence?.
Expert Review of Vaccines,
Vol. 4,
Issue. 5,
p.
757.